Use of innovation payments to encourage the adoption of new medical technologies in the English NHS

Health Policy and Technology

Volumn 2, Issue 3, 2013, Pages 168-173

  Sorenson, Corinna ^a,b   Drummond, Michael ^b,c   Wilkinson, Grahame ^a,b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b European Health Technology Institute for Socioeconomic Research (EHTI)   (Belgium)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Financing; Innovation; Medical technology; Reimbursement

Indexed keywords

ABLATION THERAPY; ARTICLE; CERVICAL DISK IMPLANT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FUNDING; HOSPITAL FINANCE; HUMAN; LOWER LIMB TRAUMA RECONSTRUCTION; MEDICAL DEVICE; MEDICAL FEE; NATIONAL HEALTH SERVICE; NEUROMODULATION IMPLANT; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; RENAL NERVE ABLATION THERAPY; TRANSCATHETER HEART VALVE; UNITED KINGDOM;

EID: 84880636972     PISSN: 22118837     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlpt.2013.05.001     Document Type: Article

References (23)

1. Barnum H., Kutzin J., Saxenian H. Incentives and provider payment methods. International Journal of Health Planning and Management 1995, 10:23-45.
2. Basu S., Hassenplug J.C. Patient access to medical devices-a comparison of U.S. and European review processes. New England Journal of Medicine 2012, 367:485-488.
3. Cappellaro G., Ghislandi S., Anessi-Pessina E. Diffusion of medical technology: the role of financing. Health Policy 2011, 100(1):51-59.
4. Congressional Budget Office (CBO). Technological change and the growth of health care spending. Washington DC: Congressional Budget Office; 2008.
5. Clyde A.T., Bockstedt L., Farkas J.A., Jackson C. Experience with Medicare's new technology add-on payment program. Health Affairs 2008, 27:1632-1641.
6. Cutler D.M. The lifetime costs and benefits of medical technology. Journal of Health Economics 2007, 26:1081-1100.
7. Cutler D.M. Technology, health costs, and the NIH. National Institute of Health Roundtable on the Economics of Biomedical Research 1995, National Institute of Health, Bethesda MD.
8. Cutler D.M., McClellan M. Is technological change in medicine worth it?. Health Affairs 2001, 20:11-29.
9. Department of Health, Payment by results guidance for 2011-2012. London: Department of Health; 2011.
10. Di Matteo L. The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time. Health Policy 2005, 71:23-42.
11. Greenhalgh T., Robert G., MacFarlane F., Bate P., Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Quarterly 2004, 82:581-629.
12. Henschke C., Baumler M., Weid S., Gaskins W., Busse R. Extrabudgetary (NUB) payments: a gateway for introducing new medical devices into the German inpatient reimbursement system?. Journal of Management and Marketing in Healthcare 2010, 3:119-133.
13. Kesteloot K., Voet N. Incentives for cooperation in quality among hospitals-the impact of the reimbursement systems. Journal of Health Economics 1998, 17:701-728.
14. Mowatt G., Bower D.J., Brebner J.A., Cairns J.A., Grant A.M., McKee L. When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies. Health Technology Assessment 1997, 1:1-149.
15. Newhouse J. Medicare care costs: how much welfare loss?. Journal of Economic Perspectives 1992, 6(2):3-21.
16. Office of Technology Assessment (OTA). Diagnosis Related Groups (DRGs) and the Medicare Program: implications for medical technology. A technical memorandum. Washington DC: Office of Technology Assessment; 1983.
17. Peden E.A., Freeland M.S. A historical analysis of medical spending growth, 1960-1993. Health Affairs 1995, 14:235-247.
18. Quentin W., Scheller-Kreinsen D., Busse R. Technological innovation in DRG-based hospital payment systems. Diagnosis-related groups in Europe: moving towards transparency, efficiency, and quality in hospitals 2011, Open University Press, Maidenhead, UK. R. Busse, A. Geissler, W. Quentin, M. Wiley (Eds.).
19. Scheller-Kreinsen D., Quentin W., Busse R. DRG-based hospital payment systems and technological innovation in 12 European countries. Value in Health 2011, 14(8):1166-1172.
20. Schreyogg J., Baumler M., Busse R. Balancing adoption and affordability of medical devices in Europe. Health Policy 2009, 92:218-224.
21. Torbica A., Cappellaro G. Uptake and diffusion of medical technology innovation in Europe: what role for funding and procurement policies?. Journal of Medical Marketing 2010, 10(1):61-69.
22. Weisbrod B.A. The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment. Journal of Economic Literature 1991, 29:523-532.
23. Freemantle N. Evaluating and regulating the device industry. British Medical Journal 2011, 342:d2839.